Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DATOPOTAMAB DERUXTECAN-DLNK: 165 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
165
Total FAERS Reports
36 (21.8%)
Deaths Reported
33
Hospitalizations
165
As Primary/Secondary Suspect
3
Disabilities
Prescription
Status

FDA Application: 761394 ·

First Report: 20250101 · Latest Report: 20250919

What Are the Most Common DATOPOTAMAB DERUXTECAN-DLNK Side Effects?

#1 Most Reported
Disease progression
49 reports (29.7%)
#2 Most Reported
Off label use
31 reports (18.8%)
#3 Most Reported
Stomatitis
27 reports (16.4%)

All DATOPOTAMAB DERUXTECAN-DLNK Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Disease progression 49 29.7% 25 8
Off label use 31 18.8% 8 6
Stomatitis 27 16.4% 3 4
No adverse event 22 13.3% 0 0
Nausea 11 6.7% 4 3
Prescribed underdose 9 5.5% 7 0
Death 7 4.2% 7 0
Interstitial lung disease 7 4.2% 1 3
Dyspnoea 6 3.6% 0 4
Mucosal inflammation 5 3.0% 0 2
Product prescribing issue 5 3.0% 0 0

Who Reports DATOPOTAMAB DERUXTECAN-DLNK Side Effects? Age & Gender Data

Gender: 89.2% female, 10.8% male. Average age: 61.4 years. Most reports from: US. View detailed demographics →

Is DATOPOTAMAB DERUXTECAN-DLNK Getting Safer? Reports by Year

YearReportsDeathsHosp.
2025 111 33 26

View full timeline →

What Is DATOPOTAMAB DERUXTECAN-DLNK Used For?

IndicationReports
Hormone receptor positive her2 negative breast cancer 55
Product used for unknown indication 30
Breast cancer 27
Breast cancer metastatic 13
Non-small cell lung cancer 10
Lung neoplasm malignant 8
Triple negative breast cancer 6

DATOPOTAMAB DERUXTECAN-DLNK vs Alternatives: Which Is Safer?

DATOPOTAMAB DERUXTECAN-DLNK vs DAUNORUBICIN DATOPOTAMAB DERUXTECAN-DLNK vs DAXIBOTULINUMTOXIN A-LANM DATOPOTAMAB DERUXTECAN-DLNK vs DAYTRANA DATOPOTAMAB DERUXTECAN-DLNK vs DECITABINE DATOPOTAMAB DERUXTECAN-DLNK vs DEFERASIROX DATOPOTAMAB DERUXTECAN-DLNK vs DEFERIPRONE DATOPOTAMAB DERUXTECAN-DLNK vs DEFEROXAMINE DATOPOTAMAB DERUXTECAN-DLNK vs DEFIBROTIDE DATOPOTAMAB DERUXTECAN-DLNK vs DEFLAZACORT DATOPOTAMAB DERUXTECAN-DLNK vs DEGARELIX

Official FDA Label for DATOPOTAMAB DERUXTECAN-DLNK

Official prescribing information from the FDA-approved drug label.